BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• BioMidwest

  Bruker Daltonics Inc. Introduces Novel LC/GC Time-of-Flight Mass Spectrometer micrOTOF™ II for LC/MS and GC/MS on One System

  June 2, 2008

   · 

  1 min read
• Business

  MAP Pharmaceuticals, Inc. Appoints Marco Rosa Vice President of Human Resources

  June 2, 2008

   · 

  2 min read
• Drug Development

  Poniard Pharmaceuticals, Inc. Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer - Poster Presented at American Society of Clinical Oncology Annual Meeting

  June 2, 2008

   · 

  6 min read
• Drug Development

  Novelos Therapeutics, Inc. Announces Presentation of Encouraging Results in Phase 2 Ovarian Cancer Trial at 2008 American Society of Clinical Oncology Meeting by MGH and Novelos Therapeutics, Inc./Harvard Cancer Centers

  June 2, 2008

   · 

  1 min read
• BioCapital

  Innovative Science and Reliable Project Management as Important as Low Cost in Selecting a Drug Discovery CRO, Says Commonwealth Biotechnologies, Inc. CEO

  June 2, 2008

   · 

  1 min read
• Drug Development

  Poniard Pharmaceuticals, Inc. Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer - Phase 2 Data To Be Presented Along With Updated Phase 1 Colorectal Cancer Data at

  June 2, 2008

   · 

  6 min read
• Business

  BioForce Nanosciences, Inc. Announces American Distribution Contract with NanoAndMore USA, Inc.

  June 2, 2008

   · 

  1 min read
• Business

  Roche Signs Exclusive Distribution Deal With DxS Ltd For K-RAS And EGFR Cancer Mutation Tests; Tests Identify Genetic Mutations That Can Affect Patient Response To Certain Cancer Drugs

  June 2, 2008

   · 

  4 min read
• Drug Development

  Medarex, Inc.'s Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma; Updated Clinical Phase 2 Data Presented at American Society of Clinical Oncology Annual Meeting

  June 2, 2008

   · 

  6 min read
• BioMidwest

  Biogen Idec, Inc. (Massachusetts) Release: New Data Show Patients Using AVONEX(R) Reported Less Sick Leave and Short-Term Disability Costs Than Patients Using Copaxone(R)

  June 2, 2008

   · 

  1 min read